2,100 Patients. 5 Villages. 2 Months. What We Found.
In 2023, Raamah Biocare conducted a pilot with the National Health Mission across 5 village clinics in Andhra Pradesh. 2,100 patients screened. Nearly 200 lesions found.
From the Clinic
Jun 3, 2025
India has one of the highest burdens of oral cancer in the world — nearly 30% of all cancers. The survival rate for Stage 1 is over 80%. For Stage 4, it drops below 20%. The gap between those numbers is not biology. It is detection.
The NHM Pilot
In 2023, Raamah Biocare conducted a pilot with the National Health Mission, Andhra Pradesh across 5 village clinics. A health worker — not a specialist — operated Dr.Oroscope after a structured training session. Result: 2,100 patients screened. Nearly 200 lesions identified. A 9.5% lesion detection rate in a population that would otherwise have had no screening at all.
What Dr.Oroscope Made Possible
CDSCO-approved. DST-funded. AI-based point-of-care diagnosis. Telemedicine referral for specialist review. Validated against Velscope across 2,430 patients in 4 government hospitals. Published in African Journal of Biological Sciences (2024).
Register interest: info@raamahbiocare.com